|
RBBP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.365240E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.316300E-02 |
| Normal-vs-Stage2 |
6.757000E-01 |
| Normal-vs-Stage3 |
4.457600E-01 |
| Normal-vs-Stage4 |
2.266600E-01 |
| Stage1-vs-Stage2 |
5.882000E-01 |
| Stage1-vs-Stage3 |
6.244600E-01 |
| Stage1-vs-Stage4 |
9.124600E-01 |
| Stage2-vs-Stage3 |
9.090800E-01 |
| Stage2-vs-Stage4 |
7.824400E-01 |
| Stage3-vs-Stage4 |
8.154400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.301400E-01 |
| Normal-vs-AfricanAmerican |
7.440000E-02 |
| Normal-vs-Asian |
1.849050E-01 |
| Caucasian-vs-AfricanAmerican |
3.980000E-01 |
| Caucasian-vs-Asian |
4.257800E-01 |
| AfricanAmerican-vs-Asian |
5.136800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.365900E-02 |
| Normal-vs-Female |
5.326000E-01 |
| Male-vs-Female |
2.862000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.141900E-02 |
| Normal-vs-Extreme_Weight |
2.030300E-02 |
| Normal-vs-Obese |
8.519000E-01 |
| Normal-vs-Extreme_Obese |
1.674030E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.755400E-01 |
| Normal_Weight-vs-Obese |
1.561990E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.966600E-01 |
| Extreme_Weight-vs-Obese |
9.740400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.195200E-01 |
| Obese-vs-Extreme_Obese |
2.513600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.544600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.426000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.154400E-02 |
| Normal-vs-Age(81-100Yrs) |
9.521900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.076800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.539800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.541780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.396160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.313000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.430400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.094200E-01 |
| Normal-VS-Type2 PRCC |
6.176700E-03 |
| Normal-VS-KIRP CIMP |
2.364000E-01 |
| Normal-VS-Unclassified PRCC |
8.782600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.212800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.270380E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.812800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.492050E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.008100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.139400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.340700E-03 |
| Normal-vs-N1 |
5.996600E-01 |
| Normal-vs-N2 |
5.844600E-01 |
| N0-vs-N1 |
6.718000E-02 |
| N0-vs-N2 |
7.875000E-01 |
| N1-vs-N2 |
5.291600E-01 |
|
|
